NEKTAR THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.75 USD | -0.28% |
|
0.00% | +209.73% |
| May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
| May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS | Other Pharmaceuticals | -0.28% | 0.00% | +209.73% | +142.45% | -94.56% | 322M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NKTR Stock
- Charts Nektar Therapeutics
- Comparison Chart